HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 53 filers reported holding HARVARD BIOSCIENCE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $650,000 | -12.8% | 121,488 | -18.5% | 0.03% | -17.6% |
Q1 2018 | $745,000 | +12.4% | 149,100 | -25.8% | 0.03% | -2.9% |
Q4 2017 | $663,000 | -7.5% | 200,964 | +5.1% | 0.04% | -16.7% |
Q3 2017 | $717,000 | +80.6% | 191,278 | +22.9% | 0.04% | +61.5% |
Q2 2017 | $397,000 | +44.9% | 155,578 | +47.9% | 0.03% | +36.8% |
Q1 2017 | $274,000 | – | 105,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |